Derek Hicks Sells $67.4K of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jan 06, 2023
Open-Market Net Sale · SEC Form 4
−$67,425
Equity position changed by -9.5%
Equity Position
17.3K sh
19,118 → 17,306
Equity Change
-9.5%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Derek Hicks CIK 0001901282 |
EVP
|
Derek Hicks at Intellia Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Intellia Therapeutics Inc
| 2025-01-07 | Sell | -$79,194 | View |
| 2024-03-05 | Award | — | View |
| 2024-01-05 | Sell | -$114,216 | View |
| 2023-03-03 | Award | — | View |
| 2022-01-05 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2023-01-04 | S - Sale | 1,812 D | $37.21 | -$67,425 | 17,306 | Direct |
Footnotes (1)
- F1
- Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 3, 2023. Show more
Related filings at Intellia Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
328
institutional managers reporting a position
Largest by reported value
- Ark Investment Management Llc $286M
- Black Rock, Inc. $261M
- State Street Corporation $156M
5%+ Holders · 13D/G
5 filers
Other insiders at Intellia Therapeutics Inc
-
John M Leonard -$108K
-
Michael P Dube -$23.2K
-
John M Leonard -$287K
-
Edward J Dulac III -$91.2K
GET /v1/forms/4/0001209191-23-002421
API docs
View Original SEC Filing